Why Gilead Sciences Stock Slipped Today Gilead Sciences (NASDAQ: GILD) didnt have a bad first quarter, but investors didnt find it inspiring either. After publishing its…
Opthea Appoints Sujal Shah to the Board of Directors Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee…
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay Therapeutics, Inc. (Nasdaq – CBAY), Everi Holdings Inc. (NYSE – EVRI), Sterling Check Corp. (Nasdaq – STER), Societal CDMO Check Corp. (Nasdaq – SCTL) BALA CYNWYD, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.…